Mrs Renee Holmes
Chair, Mitrofanoff Support
Attend this event to examine the journey of cancer patients, through treatment and into survivorship, by hearing from both patients and medical professionals.
Leading experts will lecture on management strategies for urological side effects that may result from cancer treatment and complications, such as sexual dysfunction, chronic pain and urinary problems.
We will also take time to consider the psychology of survivorship and how the medical profession can help patients navigate this journey.
Aims of this lecture include:
Book to attend this event in person or virtually. To view the rates and agenda, please select your preference below.
Follow us on:
|RSM Fellow||RSM Associate||RSM Retired Fellow||RSM Student||RSM Trainee|
|Consultant / GP / SAS Doctors||AHP / Nurse / Midwife||Student||Trainee|
|RSM Fellow||RSM Associate||RSM Retired Fellow||RSM Trainee||RSM Student|
|Consultant / GP / SAS Doctors||AHP / Nurse / Midwife||Trainee||Student|
Chair, Mitrofanoff Support
Associate Professor of Urology, University of Washington
Dr Sarah Psutka MD, MSc is an Associate Professor of Urology in the Department of Urology at the University of Washington and Fred Hutchinson Cancer Center. She received her undergraduate and medical degrees from Harvard University and completed urology residency training at the Massachusetts General Hospital. She completed a Society of Urologic Oncology Fellowship in Urologic Oncology at the Mayo Clinic, and concurrently obtained her Masters’ in Clinical and Translational Science.
Dr Psutka’s clinical efforts focus on minimally-invasive and complex open urologic oncology, with a particular interest in advanced bladder, kidney, and testis cancer. She leads the urologic oncology program at Harborview Medical Center and is the Associate Program Director of the UW Society of Urologic Oncology Fellowship Program.
Dr Psutka’s research focuses on the study and development of personalized, comprehensive risk stratification measures in patients with advanced urologic malignancies. She leads research studying the integration of principles of aging research, comprehensive geriatric assessments, body composition, and psychometric capital assessments in patients with advanced genitourinary malignancies with a focus on patient-reported outcomes and development of prehabilitation interventions. She currently leads multiple clinical trials in bladder and kidney cancer. Her research has been funded by the Bladder Cancer Advocacy Network and she was the 2022 Recipient of the Society of Urologic Oncology Young Investigator Award. She is a member of the Board of Directors of the Society of Urologic Oncology, the Society of Urologic Oncology Clinical Trials Consortium (Kidney), The Society of Urologic Oncology Fellowship Committee and Education Committee, the SWOG Clinical Trials Survivorship Committee, and the Bladder Cancer Advocacy Network Steering Committee. She was a co-founder of the Society of Women in Urologic Oncology.
Dr Psutka is the Senior Editor for the Urologic Oncology Section of the American Urological Association Core Curriculum and is an Associate Editor for European Urology.
Consultant Radiologist, University College London Hospitals NHS Trust
Professor of Urology, University Hospitals Leuven
Registration for this event will close at 1:00am on 13 October 2022. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.